Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis
Kidney Int
.
2022 Feb;101(2):415-416.
doi: 10.1016/j.kint.2021.11.013.
Epub 2021 Nov 22.
Authors
Andreas Kronbichler
1
,
Se Yong Jung
2
,
Min Seo Kim
3
,
Jae Il Shin
4
Affiliations
1
Department of Medicine, University of Cambridge, Cambridge, UK.
2
Department of Pediatrics, Division of Pediatric Cardiology, Yonsei University College of Medicine, Seoul, Korea.
3
Samsung Advances Institute for Health Sciences and Technology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
4
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. Electronic address: shinji@yuhs.ac.
PMID:
34822875
PMCID:
PMC8606315
DOI:
10.1016/j.kint.2021.11.013
No abstract available
Publication types
Letter
MeSH terms
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine
COVID-19* / prevention & control
Humans
Kidney Diseases*
Vaccination / adverse effects
Substances
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine